Insurers, Other Stakeholders Push Back Against Spending on Compounded Drugs
Health insurers, pharmacy benefit managers and other stakeholders are working to decrease spending on compounded drugs, but drug compounders are fighting back. Observers say there is "little evidence" regarding whether the compounded drugs work better than more common alternatives.
- "Pharmacies Turn Drugs Into Profits, Pitting Insurers vs. Compounders" (New York Times, 8/14).